1. Home
  2. INOD vs HRMY Comparison

INOD vs HRMY Comparison

Compare INOD & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INOD
  • HRMY
  • Stock Information
  • Founded
  • INOD 1988
  • HRMY 2017
  • Country
  • INOD United States
  • HRMY United States
  • Employees
  • INOD N/A
  • HRMY N/A
  • Industry
  • INOD EDP Services
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • INOD Technology
  • HRMY Health Care
  • Exchange
  • INOD Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • INOD 1.6B
  • HRMY 1.9B
  • IPO Year
  • INOD 1993
  • HRMY 2020
  • Fundamental
  • Price
  • INOD $82.98
  • HRMY $26.63
  • Analyst Decision
  • INOD Strong Buy
  • HRMY Strong Buy
  • Analyst Count
  • INOD 3
  • HRMY 10
  • Target Price
  • INOD $91.67
  • HRMY $50.80
  • AVG Volume (30 Days)
  • INOD 2.1M
  • HRMY 1.1M
  • Earning Date
  • INOD 11-06-2025
  • HRMY 10-28-2025
  • Dividend Yield
  • INOD N/A
  • HRMY N/A
  • EPS Growth
  • INOD 1136.64
  • HRMY 58.41
  • EPS
  • INOD 1.28
  • HRMY 3.10
  • Revenue
  • INOD $228,141,000.00
  • HRMY $772,527,000.00
  • Revenue This Year
  • INOD $48.07
  • HRMY $19.94
  • Revenue Next Year
  • INOD $21.56
  • HRMY $16.65
  • P/E Ratio
  • INOD $64.79
  • HRMY $8.61
  • Revenue Growth
  • INOD 112.54
  • HRMY 17.74
  • 52 Week Low
  • INOD $16.58
  • HRMY $25.95
  • 52 Week High
  • INOD $93.85
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • INOD 60.15
  • HRMY 31.58
  • Support Level
  • INOD $73.28
  • HRMY $25.95
  • Resistance Level
  • INOD $93.82
  • HRMY $26.92
  • Average True Range (ATR)
  • INOD 6.17
  • HRMY 0.80
  • MACD
  • INOD -1.37
  • HRMY 0.16
  • Stochastic Oscillator
  • INOD 56.53
  • HRMY 34.15

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: